As of September 26, 2026, Consensys has not filed a public S-1 registration statement with the US Securities and Exchange Commission, and no confirmed IPO date exists. Tokenist reported on July 29, 2026 that Consensys, which had engaged JPMorgan and Goldman Sachs to work toward a US listing, pushed its planned confidential S-1 filing from late February 2026 to "fall 2026 at the earliest," citing a broader crypto-market sell-off. On September 9, 2026, Fortune reported that Consensys is splitting into two entities: a standalone MetaMask company led by current CEO Joe Lubin, and a separate, institution-focused business keeping the Consensys name, led by Mike Kriak. Lubin declined to give a new IPO timeline for either entity but suggested the MetaMask unit could seek a listing as soon as early 2027. SEC EDGAR indexes US filings only, so a non-US listing route would not appear there, and no S-1 has been reported filed for Consensys or MetaMask on EDGAR as of the latest review; Segmara tracks confirmed filings and company statements, not secondary rumors.
Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases. Nothing here is investment advice.
Key points
A Confidential Filing Pushed to Fall 2026
Consensys had engaged JPMorgan and Goldman Sachs to work toward a US initial public offering and had planned to confidentially submit a draft S-1 registration statement to the Securities and Exchange Commission in late February 2026. Tokenist reported on July 29, 2026 that the company instead pushed that filing to "fall 2026 at the earliest."
Tokenist attributed the delay to a broader sell-off in crypto markets. A confidential draft S-1 is not made public and does not appear on SEC EDGAR until a company later files publicly, so there is no independent filing to check against this timeline.
MetaMask and Consensys Become Two Companies
On September 9, 2026, Fortune reported that Consensys is splitting into a standalone MetaMask company, to be led by current Consensys CEO Joe Lubin, and a separate, institution-focused entity that keeps the Consensys name, to be led by Mike Kriak.
Lubin declined to give Fortune a new IPO timeline for either entity following the split. He did suggest that the MetaMask unit could seek a listing as soon as early 2027, but that is a possibility he raised, not a filing or a confirmed date.
What Would Actually Confirm a Date
A confirmed IPO requires a public S-1 registration statement filed with the SEC and visible on EDGAR, which covers US filings only; a listing on a non-US exchange would follow that market's own regulator and filing process instead. As of the latest review, neither Consensys nor a MetaMask entity has a public filing on EDGAR, and no exchange has been named for either company. Segmara tracks confirmed filings and company statements, not rumors or secondary-market chatter, and does not predict when or whether that filing will happen.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
Metric
Value
Context
Canonical route
/blog/when-will-consensys-ipo
Stable URL path for AI and search extraction.
Article title
When Will Consensys IPO? It Split Into MetaMask, No New Date
Main page topic.
Attached public sources
2
Number of citation links rendered at the bottom of the article.
Segmara listed companies
51
Live private-company listings in the public catalogue.
Priced listings
37
Catalogue listings with visible indicative or direct marks.
Listings without an indicative price
14
Catalogue listings where a public price is intentionally not invented.
Data fingerprint chart
Visible pricing coverage72%
37 of 51 listings show a mark
Stage
Timing
Price / valuation signal
Interpretation
Chart metric
Score
Interpretation
Visible pricing coverage
72 / 100
37 of 51 listings show a mark
Analytical lens
Search intent
Searches like 'When Will Consensys IPO? It Split Into MetaMask, No New Date' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.
What counts as a listing step
For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.
Segmara role
Segmara is an independent research site. It does not sell, broker, or arrange share purchases, and nothing on this page is investment advice.
How a company reaches a US listing
The SEC filing trail
DraftThe company can first submit a draft registration statement (DRS) for confidential SEC review.
S-1 or F-1The registration statement goes public on SEC EDGAR: Form S-1, or Form F-1 for many foreign companies. A company that used a draft must file publicly at least 15 days before its roadshow.
AmendmentsS-1/A or F-1/A amendments answer SEC comments, and one of them adds the expected price range.
PricingOnce the SEC declares the registration effective, the company sets the price with its underwriters and files the final prospectus, usually a 424B4.
First tradeThe shares start trading on the exchange named in the prospectus, such as Nasdaq or the NYSE.
Consensys is not on Segmara Pro's EDGAR alert list, so no alert is posted for its filings. To look for one, search its name with EDGAR full-text search. Segmara Pro's weekly IPO brief, posted in the members forum, covers filings and pricing across the IPO calendar.
Tokenist reported on July 29, 2026 that Consensys pushed its planned US IPO -- for which it had engaged JPMorgan and Goldman Sachs -- from a late-February 2026 confidential S-1 filing to "fall 2026 at the earliest," citing a crypto-market sell-off.
On September 9, 2026, Fortune reported that Consensys is splitting into a standalone MetaMask company led by CEO Joe Lubin and a separate, institution-focused entity keeping the Consensys name, led by Mike Kriak.
Lubin declined to give a new IPO timeline for either entity but told Fortune the MetaMask unit might seek a listing as soon as early 2027 -- still no confirmed date, filing, or exchange as of the latest review.
Risk notes
Rumor risk: unofficial dates, valuations, or funding details circulating on social media or forums are frequently wrong or outdated and should not be treated as confirmation of anything.
Illiquidity risk: any private-market interest, indicative marks, or pre-IPO share arrangements in a company that has not listed can be difficult to exit and may not reflect a tradable price.
Timing risk: a company can pause, restart, or abandon IPO preparation at any stage, including after a confidential or public filing, so no step before pricing guarantees a listing.
Free: every article, the IPO calendar and the weekly IPOs page. Segmara Pro posts a weekly IPO brief in the members forum. 7-day free trial, then $15 a month (plus any applicable tax). Research only, no share sales.
Can retail investors track private-company shares on Segmara?
Yes. The free pre-IPO tracker sends indicative marks by email, with no card and no documents. Segmara does not sell, broker, or arrange share purchases.
Why was this market historically hard for retail investors to reach?
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes research simpler: anyone can follow named private companies for free, by email.
What is the easiest next step?
Open the free pre-IPO tracker first, email only. The IPO calendar is free, and Segmara Pro adds a weekly IPO brief.
Has Consensys confirmed an IPO date?
No. As of the latest review, Consensys has not filed a public S-1 with the SEC. Tokenist reported on July 29, 2026 that a planned late-February 2026 confidential S-1 filing was pushed to "fall 2026 at the earliest," and on September 9, 2026 Fortune reported that CEO Joe Lubin declined to give a new timeline after announcing Consensys would split into MetaMask and a separate Consensys entity.
Why did Consensys delay its IPO plans?
Tokenist reported on July 29, 2026 that Consensys cited a crypto-market sell-off in pushing its planned US listing -- for which it had engaged JPMorgan and Goldman Sachs -- from a late-February 2026 confidential S-1 filing to fall 2026 at the earliest.
What is the MetaMask and Consensys split?
Fortune reported on September 9, 2026 that Consensys is dividing into a standalone MetaMask company led by current CEO Joe Lubin and a separate, institution-focused entity that keeps the Consensys name, led by Mike Kriak. Lubin suggested the MetaMask unit could seek a listing as soon as early 2027.
Can I buy Consensys shares before the IPO?
Not through Segmara. Consensys is a private company, and Segmara does not sell, broker, or arrange purchases of Consensys or MetaMask shares.
Next step
Track private-market prices free.
If this article helped explain Consensys, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account.
Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases.